Treatment with Arenobufagin can reverse the EMT process of lung cancer cells by inhibiting the cascade activation of the IKKβ/NF-κB pathway, thereby effectively inhibiting the metastasis of lung cancer [94]. The gene discussed is NFKB1; the disease is lung cancer.